{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:43:36Z","timestamp":1776948216804,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.biopha.2016.08.043","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T17:31:24Z","timestamp":1471714284000},"page":"1182-1190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer"],"prefix":"10.1016","volume":"83","author":[{"given":"Yusuf","family":"Tutar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aykut","family":"\u00d6zg\u00fcr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esen","family":"Tutar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00fctfi","family":"Tutar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Pulliero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Izzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2016.08.043_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2016.08.043_bib0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.rcl.2012.06.003","article-title":"Treatment of lung cancer","volume":"50","author":"Gadgeel","year":"2012","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.biopha.2016.08.043_bib0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-5002(01)00363-4","article-title":"Chemotherapy for advanced non-small cell lung cancer: standards","volume":"34","author":"Manegold","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2174\/1389201015666140519095304","article-title":"MicroRNAs and cancer; an overview","volume":"15","author":"Tutar","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"7301","key":"10.1016\/j.biopha.2016.08.043_bib0025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nature09144","article-title":"A coding-independent function of gene and pseudogene mRNAs regulates tumour biology","volume":"465","author":"Poliseno","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.08.043_bib0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2016.08.043_bib0035","first-page":"414","article-title":"MicroRNAs in cancer treatment and prognosis","volume":"2","author":"Schoof","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2016.08.043_bib0050","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.08.043_bib0055","author":"Tutar","year":"2012","journal-title":"Pseudogenes Comp. Funct. Genomics"},{"key":"10.1016\/j.biopha.2016.08.043_bib0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mib.2014.11.012","article-title":"Taking the pseudo out of pseudogenes","author":"Goodhead","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2148-13-242","article-title":"Not so pseudo: the evolutionary history of protein phosphatase 1 regulatory subunit 2 and related pseudogenes","volume":"13","author":"Korrodi-Greg\u00f3rio","year":"2013","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0070","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1261\/rna.2658311","article-title":"Pseudogenes: pseudo-functional or key regulators in health and disease","volume":"17","author":"Pink","year":"2011","journal-title":"RNA"},{"key":"10.1016\/j.biopha.2016.08.043_bib0075","first-page":"5","article-title":"Pseudogenes newly discovered players in human cancer","author":"Poliseno","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.biopha.2016.08.043_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1389202911314020005","article-title":"In-Silico algorithms for the screening of possible microRNA binding sites and their interactions","volume":"14","author":"Dweep","year":"2013","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.biopha.2016.08.043_bib0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2174\/2211536604666141216214140","article-title":"Regulation of heat shock proteins by miRNAs in human breast cancer","volume":"3","author":"Ozgur","year":"2015","journal-title":"Microrna"},{"key":"10.1016\/j.biopha.2016.08.043_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-2164-10-277","article-title":"CellMiner: a relational database and query tool for the NCI-60 cancer cell lines","volume":"10","author":"Shankavaram","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.biopha.2016.08.043_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/2211536603666140522003539","article-title":"MicroRNAs: modulators of cell identity, and their applications in tissue engineering","volume":"3","author":"Ribeiro","year":"2014","journal-title":"Microrna"},{"key":"10.1016\/j.biopha.2016.08.043_bib0100","article-title":"Real-time quantification of microRNAs by stem-loop RT-PCR","volume":"33","author":"Chen","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0105","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.08.043_bib0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2016.08.043_bib0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/labinvest.2009.12","article-title":"Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues","volume":"89","author":"Hui","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.biopha.2016.08.043_bib0120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2016.08.043_bib0125","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0130","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1002\/anie.200801555","article-title":"Small-molecule inhibitors of microrna miR-21 function","volume":"47","author":"Gumireddy","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biopha.2016.08.043_bib0135","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6605901","article-title":"MicroRNA in lung cancer","volume":"103","author":"Lin","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5662\/wjm.v4.i2.59","article-title":"MicroRNAs in lung cancer","volume":"4","author":"Joshi","year":"2014","journal-title":"World J. Methodol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0145","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.clinbiochem.2013.01.024","article-title":"MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis","volume":"46","author":"Vannini","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biopha.2016.08.043_bib0150","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00018-014-1584-5","article-title":"Role of microRNAs in malignant mesothelioma","volume":"71","author":"Truini","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2016.08.043_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1677\/ERC-09-0184","article-title":"The role of let-7 in cell differentiation and cancer","volume":"217","author":"Boyerinas","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.2012.06646.x","article-title":"Molecular medicine and the development of cancer chemopreventive agents","volume":"1259","author":"Izzotti","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2016.08.043_bib0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2016.08.043_bib0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0175","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1158\/0008-5472.CAN-08-4277","article-title":"miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer","volume":"69","author":"Bandi","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-10-55","article-title":"miR-34a and miR-15a\/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner","volume":"10","author":"Bandi","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0185","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/cgt.2012.60","article-title":"MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression","volume":"19","author":"Zang","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2016.08.043_bib0190","article-title":"MicroRNA-34a: a potential therapeutic target in human cancer","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2016.08.043_bib0195","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.47","article-title":"Mir-34: a new weapon against cancer?","author":"Misso","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2016.08.043_bib0200","article-title":"The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells","author":"Shi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.08.043_bib0205","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.febslet.2013.08.010","article-title":"Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells","volume":"587","author":"Ke","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2016.08.043_bib0210","article-title":"miRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC","author":"Jiang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.08.043_bib0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12032-014-0195-1","article-title":"Increased micro-RNA 17, 21, and 192 gene expressions improve early diagnosis in non-small cell lung cancer","volume":"31","author":"Qi","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0220","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00099","article-title":"miR-191: an emerging player in disease biology","author":"Nagpal","year":"2014","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2016.08.043_bib0225","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","article-title":"MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)","volume":"411","author":"Zhang","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2016.08.043_bib0230","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.1073\/pnas.0905234106","article-title":"MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers","volume":"106","author":"Seike","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.08.043_bib0235","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/ijo.2013.2003","article-title":"Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicpathological and molecular features","volume":"43","author":"Capodanno","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0240","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/cdd.2011.190","article-title":"MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function","volume":"19","author":"Donzelli","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2016.08.043_bib0245","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1172\/JCI76561","article-title":"Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression","volume":"124","author":"Lin","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2016.08.043_bib0250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jrr\/rrs136","article-title":"Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway","volume":"54","author":"Duan","year":"2013","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0255","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/617868","article-title":"Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K\/Akt","author":"Ma","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2016.08.043_bib0260","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-10-0655","article-title":"Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34","volume":"70","author":"Wiggins","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0265","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.ejca.2014.06.005","article-title":"microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C","volume":"50","author":"Hu","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopha.2010.01.018","article-title":"Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis","volume":"64","author":"Gao","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.08.043_bib0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejcb.2012.11.004","article-title":"The role of miRNA-29 family in cancer","volume":"92","author":"Wang","year":"2013","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0280","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.08.043_bib0285","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.ejca.2009.09.014","article-title":"MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines","volume":"45","author":"Muniyappa","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0290","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.3760\/cma.j.issn.0366-6999.20131112","article-title":"miR-30b and miR-30c expression predicted response to tyrosine kinase inhibitors as first line treatment in non-small cell lung cancer","volume":"126","author":"Gu","year":"2013","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.biopha.2016.08.043_bib0295","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/1471-2407-14-703","article-title":"MicroRNA-30b\/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18","volume":"14","author":"Zhong","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004652","article-title":"FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs","author":"Suh","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2016.08.043_bib0305","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/bjc.2013.349","article-title":"STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells","volume":"109","author":"Lin","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2013.12.025","article-title":"miR-92a family and their target genes in tumorigenesis and metastasis","volume":"323","author":"Li","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0315","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.bbrc.2009.12.098","article-title":"miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7","volume":"391","author":"Sun","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2016.08.043_bib0320","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/abbs\/gms026","article-title":"miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A","volume":"44","author":"Zhu","year":"2012","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.biopha.2016.08.043_bib0325","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.febslet.2011.03.039","article-title":"miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5","volume":"585","author":"El Miko","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2016.08.043_bib0330","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.febslet.2012.11.004","article-title":"miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6","volume":"587","author":"Zhu","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2016.08.043_bib0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopha.2013.12.002","article-title":"MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation","volume":"68","author":"Li","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2016.08.043_bib0340","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1756-9966-29-151","article-title":"miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc","volume":"29","author":"Chen","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0345","first-page":"1747","article-title":"microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4","volume":"25","author":"Yin","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2016.08.043_bib0350","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/rna.8.1.14259","article-title":"MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1","volume":"8","author":"Cho","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0355","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ejca.2009.04.039","article-title":"Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation","volume":"45","author":"Cho","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101899","article-title":"miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma","volume":"9","author":"Tejero","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2016.08.043_bib0365","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1158\/1541-7786.MCR-10-0052","article-title":"Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer","volume":"8","author":"Ceppi","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0370","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1158\/0008-5472.CAN-13-0297","article-title":"miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer","volume":"73","author":"Cai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2016.08.043_bib0375","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.lungcan.2013.11.005","article-title":"Positive prognostic impact of miR-210 in non-small cell lung cancer","volume":"83","author":"Eilertsen","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2016.08.043_bib0380","first-page":"1621","article-title":"PUMA is a novel target of miR-221\/222 in human epithelial cancers","volume":"37","author":"Zhang","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2016.08.043_bib0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156652412798376170","article-title":"miR221\/222 in cancer: their role in tumor progression and response to therapy","volume":"12","author":"Garofalo","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.biopha.2016.08.043_bib0390","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bone.2012.10.033","article-title":"miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis","volume":"52","author":"Valencia","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2016.08.043_bib0395","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1073\/pnas.1215938110","article-title":"TPL2 kinase is a suppressor of lung carcinogenesis","volume":"110","author":"Gkirtzimanaki","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2016.08.043_bib0400","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3892\/ijmm.2013.1439","article-title":"miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2","volume":"32","author":"Qiu","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2016.08.043_bib0405","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2013.01.028","article-title":"MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth","volume":"333","author":"Zhou","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2016.08.043_bib0410","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/ijc.28799","article-title":"MiR-503 targets PI3K p85 and IKK-\u03b2 and suppresses progression of non-small cell lung cancer","volume":"135","author":"Yang","year":"2014","journal-title":"Int. J. Cancer"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216306916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216306916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:41:50Z","timestamp":1776944510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216306916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":82,"alternative-id":["S0753332216306916"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2016.08.043","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2016.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}